The European Medicines Agency re-examined clinical data of a subset of patients with one or no copies of the APOE4 gene ...

Michael Yee has given his Buy rating due to a combination of factors including the recent positive developments regarding Biogen’s Alzheimer’s drug, Leqembi, in the European market. The European ...

European regulators initially said in July that the drug's benefits did not outweigh its risks. View on euronews ...

Worldwide Healthcare Trust PLC - Half-year Report PR Newswire LONDON, United Kingdom, November 15 LONDON STOCK EXCHANGE ANNOUNCEMENTWorldwide Healthcare Trust PLCUnaudited ...